Skip to main content
Top
Published in: Gastric Cancer 5/2019

01-09-2019 | Gastric Cancer | Short Communication

Gastric cancer mortality rates among US and foreign-born persons: United States 2005–2014

Authors: Benjamin D. Hallowell, Meheret Endeshaw, Virginia Senkomago, Hilda Razzaghi, Matthew T. McKenna, Mona Saraiya

Published in: Gastric Cancer | Issue 5/2019

Login to get access

Abstract

Background

Historically, foreign-born individuals in the US have had an elevated risk of dying from gastric cancer when compared to US-born individuals. This is primarily due to factors that occur prior to their immigration to the US, including diet and underlying risk of H. pylori infection.

Methods

National mortality data from 2005 to 2014 were obtained from the CDC’s National Center for Health Statistics. Annual population estimates were obtained from the US Census Bureau’s American Community Survey for foreign-born and US-born persons. Age-adjusted gastric cancer mortality rates and rate ratios (RR) were calculated stratified by birth place, age, race/ethnicity, and geographic location.

Results

From 2005 to 2014, 111,718 deaths from malignant gastric cancer occurred in the US, of which 24,583 (22%) occurred among foreign-born individuals. Overall, foreign-born individuals had higher mortality rates compared with US-born individuals (RR 1.82; 95% CI 1.80, 1.85) and this difference remained after stratifying by sex, age, and geographic location. However, this finding was primarily driven by the low rate of gastric cancer mortality among US-born whites, with similar mortality rates observed among all other foreign-born and US-born groups. Gastric cancer mortality rates significantly decreased during the study period overall (AAPC − 2.50; 95% CI − 3.21, − 1.79) with significant declines observed among US-born (AAPC − 2.81; 95% CI − 3.55, − 2.07) and the foreign-born (AAPC − 2.53; 95% CI − 3.20, − 1.86) population.

Conclusions

Efforts directed at reducing the prevalence of gastric cancer risk factors could help reduce the elevated burden observed among foreign-born individuals and US-born minority groups.
Literature
2.
go back to reference Compare D, Rocco A, Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci. 2010;14(4):302–8.PubMed Compare D, Rocco A, Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci. 2010;14(4):302–8.PubMed
3.
go back to reference Stewart B, Wild CP. World cancer report 2014. 1. Lyon: International Agency for Research on Cancer; 2014. Stewart B, Wild CP. World cancer report 2014. 1. Lyon: International Agency for Research on Cancer; 2014.
4.
go back to reference Plummer M, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–16.CrossRef Plummer M, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–16.CrossRef
5.
go back to reference Hooi JK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.CrossRef Hooi JK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.CrossRef
6.
go back to reference U.S. Cancer Statistics Working Group. United States Cancer statistics: 1999–2015 incidence and mortality web-based report. U.S. Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute, Editor; 2018. U.S. Cancer Statistics Working Group. United States Cancer statistics: 1999–2015 incidence and mortality web-based report. U.S. Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute, Editor; 2018.
7.
go back to reference Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979–2003. Int J Epidemiol. 2006;35(4):903–19.CrossRefPubMed Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979–2003. Int J Epidemiol. 2006;35(4):903–19.CrossRefPubMed
8.
go back to reference Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health. 2004;95(3):14–21. Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health. 2004;95(3):14–21.
9.
10.
go back to reference El-Serag HB, et al. Houston consensus conference on testing for Helicobacter pylori infection in the United States. Clin Gastroenterol Hepatol. 2018;16(7):992–1002.CrossRefPubMed El-Serag HB, et al. Houston consensus conference on testing for Helicobacter pylori infection in the United States. Clin Gastroenterol Hepatol. 2018;16(7):992–1002.CrossRefPubMed
12.
go back to reference Surveillance Research Program National Cancer Institute. SEER*Prep software. Bethesda: National Cancer Institute; 2016. Surveillance Research Program National Cancer Institute. SEER*Prep software. Bethesda: National Cancer Institute; 2016.
13.
go back to reference Surveillance Research Program National Cancer Institute. SEER*Stat software. Bethesda: National Cancer Institute; 2017. Surveillance Research Program National Cancer Institute. SEER*Stat software. Bethesda: National Cancer Institute; 2017.
14.
go back to reference Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2011;175(1):54–9.CrossRefPubMedPubMedCentral Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2011;175(1):54–9.CrossRefPubMedPubMedCentral
15.
go back to reference Rizo-Ríos P, et al. Trends in cancer mortality in Mexico: 1990–2012. Revista Médica Del Hospital General De México. 2015;78(2):85–94.CrossRef Rizo-Ríos P, et al. Trends in cancer mortality in Mexico: 1990–2012. Revista Médica Del Hospital General De México. 2015;78(2):85–94.CrossRef
16.
go back to reference Kim GH, et al. Screening and surveillance for gastric cancer in the United States: is it needed? Gastrointest Endosc. 2016;84(1):18–28.CrossRefPubMed Kim GH, et al. Screening and surveillance for gastric cancer in the United States: is it needed? Gastrointest Endosc. 2016;84(1):18–28.CrossRefPubMed
17.
go back to reference Ford AC, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. Bmj. 2014;348:g3174.CrossRefPubMedPubMedCentral Ford AC, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. Bmj. 2014;348:g3174.CrossRefPubMedPubMedCentral
18.
go back to reference Leung WK, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.CrossRef Leung WK, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.CrossRef
19.
go back to reference Chey WD, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212.CrossRefPubMed Chey WD, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212.CrossRefPubMed
20.
go back to reference Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—“ABC method”. Proc Jpn Acad Ser B. 2011;87(7):405–414.CrossRef Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—“ABC method”. Proc Jpn Acad Ser B. 2011;87(7):405–414.CrossRef
Metadata
Title
Gastric cancer mortality rates among US and foreign-born persons: United States 2005–2014
Authors
Benjamin D. Hallowell
Meheret Endeshaw
Virginia Senkomago
Hilda Razzaghi
Matthew T. McKenna
Mona Saraiya
Publication date
01-09-2019
Publisher
Springer Singapore
Published in
Gastric Cancer / Issue 5/2019
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-019-00944-w

Other articles of this Issue 5/2019

Gastric Cancer 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.